Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-08

Clinical Trial Update: Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With Rosacea [Phase 3]

View source ↗

Summary

Phase 3 trial update for a topical gel (CD07805/47) in facial erythema due to rosacea, with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CD07805/47 Topical Gel (CD07805/47 topical gel)

Snippet

Sponsor: Galderma R&D | Conditions: Rosacea | Phase 3 | Status: COMPLETED | Results posted: 2014-01-08